The first study implicating ANXA2 expression with tPA production was conducted in 1998 and demonstrated high expression levels of uPAR and ANXA2 in pancreatic cancer cells compared to normal cultures where both receptors were found to be localised in the basolateral membrane in SK-PC1 cells [176]. Here, ANXA2 is linked to pancreatic neoplasm.